Omega Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
04 Feb 2025	Form 3: Varsalone Jeffrey T, Director No securities owned
05 Dec 2024	Form 3: Mehrotra Ravi, Director No securities owned
26 Nov 2024	Form 3: Nelson Jennifer Ann, Chief Scientific Officer
04 Oct 2024	Form 3: Rosiello Robert L., Director No securities owned
21 Jun 2024	Form 3: Kender Richard N, Director No securities owned
31 May 2024	Form 3: Certel Kaan, Chief Business Officer No securities owned
31 May 2024	Form 3: Chan Barbara Y, Chief Accounting Officer Holds 37,683 shares of Common Stock
29 Aug 2023	Form 3: Werner Michelle C, Director No securities owned
12 Jul 2023	Form 3: Schade Christian S, Director No securities owned
27 Feb 2023	Form 3: Flagship Pioneering Fund Vii General Partner Llc, 10% owner and 1 other Holds 1,329,324 shares of Common Stock
01 Sep 2022	Form 3: Boehm Rainer J., Director No securities owned
02 Jun 2022	Form 3: Reed Joshua, Chief Financial Officer No securities owned
01 Apr 2022	Form 3: McManus Kevin, Chief Human Resources Officer No securities owned
01 Apr 2022	Form 3: Zeng Ling, See Remarks No securities owned
06 Jan 2022	Form 3: Moore Yan, Chief Medical Officer No securities owned
29 Jul 2021	Form 3: Flagship Pioneering Inc., Director and 5 others Holds 2,197,059 shares of Common Stock
29 Jul 2021	Form 3: Mendlein John, Director
29 Jul 2021	Form 3: Levy Elliott M., Director
29 Jul 2021	Form 3: Young Richard A, Director Holds 794,118 shares of Common Stock
29 Jul 2021	Form 3: Sawhney Roger, Chief Financial Officer

Comments